Martingale Asset Management L P Kiniksa Pharmaceuticals, Ltd. Transaction History

Martingale Asset Management L P

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$14.37 - $19.07 $201 - $266	14 Added 0.03%	45,377 $795,000
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $27 - $40	2 Added 0.0%	45,363 $787,000
Q2 2023 Aug 11, 2023	BUY	$10.44 - $16.48 $12,611 - $19,907	1,208 Added 2.74%	45,361 $638,000
Q1 2023 May 12, 2023	BUY	$10.7 - $15.79 $10,710 - $15,805	1,001 Added 2.32%	44,153 $475,000
Q4 2022 Feb 13, 2023	BUY	$11.42 - $17.05 $125 - $187	11 Added 0.03%	43,152 $646,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $32,295 - $44,373	3,309 Added 8.31%	43,141 $554,000
Q2 2022 Aug 11, 2022	BUY	$7.6 - $11.41 $21,409 - $32,141	2,817 Added 7.61%	39,832 $385,000
Q1 2022 May 12, 2022	BUY	$9.3 - $12.37 $13,029 - $17,330	1,401 Added 3.93%	37,015 $367,000
Q4 2021 Feb 11, 2022	SELL	$10.39 - $15.15 $2,078 - $3,030	-200 Reduced 0.56%	35,614 $419,000
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $239,212 - $340,862	21,002 Added 141.79%	35,814 $407,000
Q1 2021 May 13, 2021	SELL	$16.68 - $23.97 $1,668 - $2,397	-100 Reduced 0.67%	14,812 $274,000
Q4 2020 Feb 10, 2021	SELL	$14.8 - $21.15 $719,280 - $1.03 Million	-48,600 Reduced 76.52%	14,912 $263,000
Q3 2020 Nov 12, 2020	SELL	$15.21 - $25.53 $366,484 - $615,145	-24,095 Reduced 27.5%	63,512 $973,000
Q2 2020 Aug 10, 2020	BUY	$15.08 - $26.0 $1.32 Million - $2.28 Million	87,607 New	87,607 $2.23 Million

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.